Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SHE:301234)

SHE:301234 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	480.05	477.23	533.5	546.78	512.79	471.15
Other Revenue	0.2	0.2	0.18	0.33	0.18	0.09
Revenue	480.25	477.43	533.68	547.11	512.96	471.24
Revenue Growth (YoY)	4.04%	-10.54%	-2.46%	6.66%	8.85%	-3.23%
Cost of Revenue	408.72	395.53	422.68	428.74	399.7	376.45
Gross Profit	71.53	81.9	111	118.38	113.26	94.79
Selling, General & Admin	38.35	33.06	35.25	43.31	19.93	19.18
Research & Development	10.27	12.97	13.48	13.09	11.78	10.02
Other Operating Expenses	8.76	1.54	1.56	1.82	2.6	2.09
Operating Expenses	57.12	49.35	53.43	63.13	35.07	31.27
Operating Income	14.42	32.55	57.56	55.25	78.19	63.51
Interest Expense	-0.03	-0.02	-0.01	-0.63	-1.03	-1.06
Interest & Investment Income	5.7	5.69	8.72	2.11	2.29	1.99
Currency Exchange Gain (Loss)	5.66	5.66	3.56	7.06	-2.49	-7.8
Other Non Operating Income (Expenses)	-1.38	-0.91	-1.37	-0.65	-0.81	-0.48
EBT Excluding Unusual Items	24.37	42.97	68.46	63.14	76.15	56.16
Gain (Loss) on Sale of Investments	0.84	0.9	-1.34	-6.15	-	7.15
Gain (Loss) on Sale of Assets	-0.17	0.01	-	-	-0.47	-
Asset Writedown	0.45	-0.32	-0.47	-1.94	-0.01	-
Other Unusual Items	3.81	2.89	4.29	18.4	4.17	5.29
Pretax Income	29.29	46.45	70.94	73.45	79.84	68.6
Income Tax Expense	5.14	6.49	10.67	2.52	11.45	11.86
Net Income	24.14	39.97	60.27	70.93	68.39	56.74
Net Income to Common	24.14	39.97	60.27	70.93	68.39	56.74
Net Income Growth	-40.47%	-33.68%	-15.04%	3.71%	20.53%	7.27%
Shares Outstanding (Basic)	68	68	68	60	51	51
Shares Outstanding (Diluted)	68	68	68	60	51	51
Shares Change (YoY)	-0.01%	0.00%	14.28%	16.66%	-0.24%	0.50%
EPS (Basic)	0.36	0.59	0.89	1.19	1.34	1.11
EPS (Diluted)	0.36	0.59	0.89	1.19	1.34	1.11
EPS Growth	-40.46%	-33.68%	-25.65%	-11.10%	20.81%	6.73%
Free Cash Flow	56.67	51.9	10.92	-52.51	6.07	21.31
Free Cash Flow Per Share	0.83	0.76	0.16	-0.88	0.12	0.42
Dividend Per Share	0.300	0.300	0.400	0.500	-	-
Dividend Growth	-25.00%	-25.00%	-20.00%	-	-	-
Gross Margin	14.89%	17.16%	20.80%	21.64%	22.08%	20.11%
Operating Margin	3.00%	6.82%	10.79%	10.10%	15.24%	13.48%
Profit Margin	5.03%	8.37%	11.29%	12.96%	13.33%	12.04%
Free Cash Flow Margin	11.80%	10.87%	2.04%	-9.60%	1.18%	4.52%
EBITDA	57.5	70.13	87.81	77.7	96.36	77.12
EBITDA Margin	11.97%	14.69%	16.45%	14.20%	18.79%	16.36%
D&A For EBITDA	43.08	37.58	30.25	22.45	18.17	13.61
EBIT	14.42	32.55	57.56	55.25	78.19	63.51
EBIT Margin	3.00%	6.82%	10.79%	10.10%	15.24%	13.48%
Effective Tax Rate	17.56%	13.96%	15.05%	3.43%	14.34%	17.28%
Revenue as Reported	480.25	477.43	533.68	547.11	512.96	471.24
Advertising Expenses	-	1.65	1.44	0.78	0.66	0.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.